Small Pharmaceutical Firms Building Capabilities to Compete Along the Global Research and Development Pipeline

Author(s):  
Lisette Pregelj ◽  
Martie-Louise Verreynne ◽  
Damian Hine
2020 ◽  
Vol 39 (3) ◽  
pp. 564-586
Author(s):  
Anita Rao

Do pharmaceutical firms respond to the actions of their competitors in R&D, and if so, what implications does this have for policies aimed at incentivizing drug development?


Sign in / Sign up

Export Citation Format

Share Document